Serenex, of Durham, has secured $31 million in financing, including a $26 million Series D private placement of preferred stock and a $5 million working capital debt facility.(FINANCING)
Publication Date: 01-JUL-07
Publication Title: BT Catalyst
Format: Online

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

Serenex, of Durham, has secured $31 million in financing, including a $26...



More articles from BT Catalyst
Biolex Therapeutics of Pittsboro closed on a $30 million Series C fina..., July 01, 2007
Viamet Pharmaceutical, a Research Triangle park biotechnology company ..., July 01, 2007
Entegrion, a Research Triangle park biotechnology spin-out of Universi..., July 01, 2007
LaamScience, a Research Triangle park-based company founded on a disco..., July 01, 2007
The Piedmont Angel Network Two (PAN Two), a structured, committed capi..., July 01, 2007

Looking for additional articles?
Click here to search our database of over 3 million articles.